HHS - Latest News
Harte Hanks, Inc. (HHS), operates in Communication Services / Advertising Agencies, trades on NASDAQ.
Market capitalization stands near $19.6M. Beta to the broader market is -0.03.
The article list below shows the most recent HHS headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent HHS Headlines
Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States
gurufocus.com - May 19, 2026
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced
Harte Hanks Reports First Quarter 2026 Results
accessnewswire.com - May 14, 2026
Advances Sector-Aligned Growth Strategy While Maintaining Strong Balance Sheet and Positive EBITDA CHELMSFORD, MA / ACCESS Newswire / May 14, 2026 / H
Harte Hanks Reports Fourth Quarter and Fiscal 2025 Full-Year Results
accessnewswire.com - Mar 17, 2026
Reports Positive FY 2025 EBITDA CHELMSFORD, MA / ACCESS Newswire / March 17, 2026 / Harte Hanks, Inc. (NASDAQ:HHS), a leading global customer experie
How News Affects HHS Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track HHS's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked HHS news questions
- What is the latest HHS news headline?
- The most recent HHS headline (May 19, 2026) is "Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the HHS news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What HHS news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual HHS options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.